Notice 9 Sep 2025 healthcare, regulatory compliance, cdc, drug testing, laboratories, public health

🧪CDC Requests Comments on Drug Susceptibility Testing Program

The CDC has submitted an information collection request for the Model Performance Evaluation Program related to Mycobacterium tuberculosis drug susceptibility testing. This initiative aims to enhance the quality of testing practices among U.S. laboratories. The program is designed to provide evaluations that help optimize laboratory capabilities in identifying drug-resistant tuberculosis strains, thereby informing continuous program improvement.

Learn More
Notice 9 Sep 2025 tobacco industry, ingredient reporting, regulatory compliance, cdc, public health

🏭CDC Proposes Data Collection on Cigarette Ingredients

The Centers for Disease Control and Prevention (CDC), as part of its continuing effort to reduce public burden and maximize the utility of government information, invites the general public and other Federal agencies the opportunity to comment on a continuing information collection, as required by the Paperwork Reduction Act of 1995. This notice invites comment on a continuing information collection project titled List of Ingredients Added to Tobacco in the Manufacture of Cigarette Products. This data collection is developed so that cigarette manufacturers, packagers, and importers can submit annually to HHS (through CDC) a list of ingredients added to tobacco in the manufacturing of cigarettes.

Learn More
Notice 8 Sep 2025 financial assistance, public health, sickle cell disease, grant, usa, healthcare

💰Supplemental Awards Announced for Sickle Cell Disease Programs

HRSA will provide $65,500 in supplemental award funds to each of the 25 Sickle Cell Disease (SCD) Newborn Screening Follow-Up Program (NBS FP) grantees under HRSA-21-036 in fiscal year (FY) 2025, totaling $1,637,500. The FY 2025 supplemental funds will support grant activities that are in scope of program goals and objectives. The supplemental funding can support activities related to: increasing access to medical and support services, particularly during the pediatric to adult transition period; improving data systems; increasing workforce training and knowledge; expanding quality improvement projects; or conducting outreach to help identify individuals living with SCD who have been lost to follow-up. These activities will strengthen the linkage of individuals with SCD to appropriate and ongoing care to improve health outcomes.

Learn More
Notice 5 Sep 2025 public health, food safety, state programs, fda, manufactured food, regulatory compliance

🍽️FDA's Manufactured Food Regulatory Program Standards Overview

The Food and Drug Administration (FDA or we) is announcing that a proposed collection of information has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995.

Learn More
Presidential Document 3 Sep 2025 public health, overdose prevention, drug crisis, national initiative, community awareness

💊Proclamation for Overdose Prevention Week

A Proclamation by the President emphasizes the commitment to ending the drug overdose crisis in America. It marks August 31 through September 6, 2025, as Overdose Prevention Week, urging Americans to participate in awareness programs and activities that address the opioid epidemic and support affected communities.

Learn More
Notice 29 Aug 2025 regulatory compliance, healthcare, public health, cdc, vaccines, acip

💉CDC Announces Meeting on Immunization Practices and Public Comment

In accordance with the Federal Advisory Committee Act, the Centers for Disease Control and Prevention (CDC) announces the following meeting of the Advisory Committee on Immunization Practices (ACIP). Time will be available for public comment.

Learn More
Notice 28 Aug 2025 regulatory compliance, healthcare, public health, workforce development, nurse corps, scholarships

🎓Nurse Corps Scholarship Program OMB Review Notice

In compliance with the Paperwork Reduction Act of 1995, HRSA submitted an Information Collection Request (ICR) to the Office of Management and Budget (OMB) for review and approval. Comments submitted during the first public review of this ICR will be provided to OMB. OMB will accept further comments from the public during the review and approval period. OMB may act on HRSA's ICR only after the 30-day comment period for this notice has closed.

Learn More
Notice 26 Aug 2025 compliance, federal regulations, funding opportunities, data management, public health, cdc

📊CDC Seeks Comments on Proposed Data Management Plan Template

The Centers for Disease Control and Prevention (CDC), as part of its continuing effort to reduce public burden and maximize the utility of government information, invites the general public and other federal agencies the opportunity to comment on a proposed information collection, as required by the Paperwork Reduction Act of 1995. This notice invites comment on a proposed information collection project titled Data Management Plan (DMP) Template. The proposed data collection will allow CDC to have a consistent and unified approach for CDC Programs to develop their own Data Management Plans (DMPs).

Learn More
Notice 22 Aug 2025 compliance, information collection, fda, public health, youth protection, tobacco regulations

🚭FDA Regulation on Tobacco Sales to Shield Children and Adolescents

The Food and Drug Administration (FDA or Agency) is announcing an opportunity for public comment on the proposed collection of certain information by the Agency. Under the Paperwork Reduction Act of 1995 (PRA), Federal Agencies are required to publish notice in the Federal Register concerning each proposed collection of information, including each proposed extension of an existing collection of information, and to allow 60 days for public comment in response to the notice. This notice solicits comments on the collection of information entitled, "Regulations Restricting the Sale and Distribution of Cigarettes and Smokeless Tobacco to Protect Children and Adolescents."

Learn More
Notice 22 Aug 2025 trade, import/export, public health, business opportunities, health regulation

🐾CDC Rescinds Civet Import Embargo

Based on a review of existing import requirements, CDC has determined that the import requirements for civets (Family: Viverridae) are no longer necessary to protect the public's health and should therefore be rescinded. Accordingly, effective immediately, CDC is rescinding its embargo on the importation of civets (Family: Viverridae).

Learn More